This Week in Psychedelics - 2.25.22

Cannabis

• Where Is The Cannabis Industry Headed In 2022? (Forbes)

• The Media’s War on Cannabis (Volteface)

• Michigan marijuana recall reversal let businesses sell contaminated cannabis (MLive.com)

• Why you still can’t buy legal pot in N.J. 16 months after voters gave the go-ahead (The Philadelphia Inquirer)

• Customers At South Dakota’s Only Medical Dispensary Still Getting Arrested (High Times)

• The US cannabis industry now supports 428,059 jobs (Leafly)

• Cannabis shown to be an effective treatment option for back pain: Study review (The GrowthOp)

• New Law Could Help Free Louisiana Man Serving Life in Prison For Cannabis (High Times)

• South Dakota Governor Won’t Rule Out Vetoing Marijuana Legalization Bill That Passed The Senate (Marijuana Moment)

• New Zealand Police Reboot Illegal Cannabis Operation Search After Year of Inactivity (High Times)

• Marijuana Legalization Bill Heads To Delaware House Floor Following Second Committee Approval (Marijuana Moment)

• Oregon Lawmakers Take On State’s Illicit Pot Operations (High Times)

• Maryland Lawmakers Vote To Put Marijuana Legalization Referendum On November Ballot (Marijuana Moment)

• London drug trial a vital but ‘tiny’ step (Green World)

• College Students Who Use Marijuana Show Signs Of Greater Motivation Compared To Non-Users, Study Finds (Marijuana Moment)

• California Bill Would Protect Cannabis Users From Employment Discrimination (High Times)

• Our outdated marijuana laws put Americans in danger. It's past time for federal cannabis reforms. (USA Today)

• Three In Four Florida Voters Support Legalizing Marijuana, New Poll Finds (Marijuana Moment)

Magic Mushrooms

• Psilocybe ovoideocystidiata: The Ohio Valley Shroom Taking Over the World (DoubleBlind)

• Probing How Magic Mushrooms Might Help Cure Addiction (Discover)

• Oregon Senators Approve Psilocybin Equity Bill In Committee (Marijuana Moment)

• Oklahoma Lawmakers Pass Psilocybin Bill in Committee (Truffle Report)

• Second Hawaii Senate Committee Approves Psilocybin Task Force Bill, With Decriminalization Measures Still Pending (Marijuana Moment)

• Can ‘magic mushrooms’ make the trip to legal in conservative Utah? (The Salt Lake Tribune)

MDMA

• MDMA Doesn't Actually Cause Comedowns, New Study Finds (VICE)

DMT

• New study offers a detailed glimpse into the otherworldly encounters produced by the psychedelic drug DMT (PsyPost)

• The First-Ever Clinical Trial For DMT Use In Major Depressive Disorder Show Promise (The Dales Report)

• Tackling Trauma with Pharmahuasca and DMT (Psychedelic Science Review)

Mescaline

• Lophos Pharma: Exploring the Potential of Mescaline (Truffle Report)

Iboga

• Gabon Takes First Step Toward Legal Export of Sustainable Iboga (Lucid News)

Nitrous Oxide

• No laughing matter: sale of nitrous oxide banned to minors (The Brussels Times)

Ketamine

• N.B. clinic brings psychedelic drug to mainstream to treat PTSD (CBC)

Miscellaneous

• The Insights Psychedelics Give You Aren’t Always True (VICE)

• Your Brain on Psychedelics Might Look the Same as Your Brain on Religious Mysticism (DoubleBlind)

• Top Federal Drug Agency Funds Research On Differing Legal Marijuana Regulatory Models (Marijuana Moment)

• California’s Proposed Psychedelic Decrim Bill Paused in State Assembly (Lucid News)

• The Corporatization of Psychedelics Would Be a Disaster (Jacobin)

• Police Keep Arresting People For Drugs Even As Incarceration Rates Drop, Pew Study Finds (Marijuana Moment)

• Reclaiming Ownership of Your Body With Psychedelics (Psychedelics Today)

• At Harvard, Psychedelic Drugs' Tentative Renaissance (The Harvard Crimson)

• Utah Senate Committee Approves Psychedelics Study Task Force Bill That Already Passed House (Marijuana Moment)

• Is the Hype Around Psychedelics Bursting? (Psychology Today)

• What’s Next for Australia’s Psychedelics Movement? (Truffle Report)

• Why Victoria should review its response to drugs and decriminalise usage (The Age)

• After Its Vilification In The 1960s, There Is Now A Renaissance In Psychedelic Drugs To Help Treat Depression And Mental Health Issues (Forbes)

• Do Psychedelic Drug Therapies Actually Require Getting High? (Discover)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 2.18.22

Cannabis

• Virginia Senate Votes To Start Recreational Marijuana Sales This September Through Current Medical Dispensaries (Marijuana Moment)

• Sha’Carri Richardson, Suspended Over Marijuana, Suggests Racist Double Standard After Olympics Lets Russian Skater Compete Amid Doping Scandal (Marijuana Moment)

• Israel Announces New Cannabis Decriminalization Plans (High Times)

• Apple Secretly Joined Amazon In Advancing Commercial Cannabis Reform (Forbes)

• New York Lawmakers Send Marijuana Licensing And Equity Bill To Governor’s Desk (Marijuana Moment)

• South African Government to Fast Track Cannabis Reform Regulations (High Times)

• D.C. Mayor Signs Bill To Let Older Patients Get Medical Marijuana Without Doctors And Create 4/20 Cannabis Tax Holiday (Marijuana Moment)

• Marijuana for trauma: Report shows positive effects of medical cannabis (The Jerusalem Post)

• Hawaii Senate Committee Approves Bill To Legalize Marijuana For Senior Citizens 65 And Older (Marijuana Moment)

• Bill To Create State-Run Marijuana Shops In New Hampshire Approved By House (Marijuana Moment)

• Alabama Senators Approve Marijuana Decriminalization And Expungements Bill In Committee (Marijuana Moment)

• South Dakota Lawmakers Approve Marijuana Legalization And Taxation Bills In Committee (Marijuana Moment)

• WA researchers look at potential to use medicinal cannabis for weight loss (Australian Broadcasting Corporation)

• GOP Missouri Lawmaker Unveils Wide-Ranging Marijuana Legalization Bill As Others Pursue 2022 Ballot (Marijuana Moment)

• Kentucky Democrats File Bills To Legalize Marijuana (Marijuana Moment)

• Lawmakers, Cops Consider Adult-Use Cannabis Legalization in Pennsylvania (NORML)

• Wyoming Legislators Introduce Cannabis Decriminalization Bill (High Times)

• Maryland Lawmakers Take First Step To Putting Marijuana Legalization On 2022 Ballot With Hearing On Two Bills (Marijuana Moment)

• New York Senate OKs bill to allow hemp farmers to grow adult-use marijuana (Marijuana Business Daily)

• Majority Of Arkansas Voters Back Cannabis Legalization (High Times)

• IRS Official Clarifies That Medical Marijuana Is Not Tax-Deductible Under Federal Law After Misstatement (Marijuana Moment)

• Proposed Bill Could Protect Employees in Colorado who Use Cannabis (High Times)

• Hemp-Reinforced Bobsled and Luge Tracks Debut at Winter Olympics in Beijing (High Times)

LSD

• Another trial finds no evidence LSD microdosing does anything (New Atlas)

• LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility (Beckley Foundation)

• New study addresses the question; ‘Can LSD boost creativity?’ (leafie)

Magic Mushrooms

• Psilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients, Study Shows (Johns Hopkins)

• Top Italian Court Blocks Marijuana And Psilocybin Referendum From Going Before Voters (Marijuana Moment)

• Psilocybin use associated with lowered odds of having been arrested, study finds (PsyPost)

• Oklahoma Lawmakers Approve Psilocybin Decriminalization And Research Bill In Committee (Marijuana Moment)

• Mushroom rabbi grows ceremonial psilocybin for Denver congregation — but is that legal? (The Denver Post)

• Hawaii Senators Approve Psilocybin Task Force Bill In Committee, With Decriminalization Measures Still Pending (Marijuana Moment)

• Oregon proposes only using one type of mushroom for new psilocybin system, and no pills (OPB)

• Nova Mentis Study Confirms Oral Microdose Psilocybin Treatment of Autism (Psilocybin Alpha)

• These Four Companies Want to Take You on a Psychedelic Voyage in Oregon (Willamette Week)

• No Need for Magic Mushrooms? Producing Synthetic Psilocybin from Bacteria and Yeast (Truffle Report)

• Psyched Wellness Announces Key Findings from the 90-Day Oral Toxicity Study on AME-1 (Psilocybin Alpha)

MDMA

• Bar-Goers Were Poisoned by Ecstasy-Laced Champagne, German Police Say (Gizmodo)

DMT

• The Latest in DMT Research: Leading Companies and Key Studies (Truffle Report)

• What is DMT therapy? (Drug Science)

Ayahuasca

• Deontay Wilder contemplates using ayahuasca to help decide his boxing future (leafie)

• When Is Drinking Ayahuasca a Religious Experience? (Reason)

5-MeO-DMT

• More Companies Embrace 5-MeO-DMT to Create Therapies (Lucid News)

Peyote

• Calling on Federal, State, and Local Governments to Protect and Respect Peyote (Lophophora williamsii) and its Byproducts (Chacruna)

• How peyote — used as a ceremonial, legal medicine — helped heal one family’s grief (Rocky Mountain PBS)

Novel Psychoactive Substances

• Mydecine Announces MYCO-005 Family of Improved Safety Microdose Novel Molecules (Psilocybin Alpha)

• Awakn Files Patent For A New Class Of Entactogen-Like Molecules (Psilocybin Alpha)

Synthetic Cannabinoids

• Report finds too many New Zealanders are dying from preventable drug overdoses (Newshub)

Nitrous Oxide

• Doctors warn of emerging public health issue from recreational use of laughing gas (Irish Examiner)

Ketamine

• Ketamine No Better Than Placebo for Reducing Suicidal Ideation in Depression (Mad in America)

• Ehave, Inc. Launches KetaDASH, Its In-Home Ketamine Therapy In The San Francisco And Sacramento Market (GlobeNewswire)

• FDA: Safety Concerns With Compounded Ketamine Nasal Spray (MPR)

• PharmaTher Announces Grant of U.S. Patent on Ketamine Formulation (Psilocybin Alpha)

Miscellaneous

• Judge Grants Hearing for Opposition to DEA Proposal to Criminalize 5 More Psychedelics (Psychedelic Spotlight)

• MAPS Accepts $500,000 Donation From Atai Life Sciences’ Philanthropy Arm (Forbes)

• Maryland Senators Propose Free Psychedelics for Veterans with PTSD (Truffle Report)

• Psychedelics Open Opportunity to Study Synesthesia (Lucid News)

• Trauma and Vulnerability to Suggestion: Redefining How We Understand Consent (Psychedelics Today)

• The Psychonaut’s Guide to Kabbalah and Spiritual Journeying (DoubleBlind)

• What Are the Prospects for Canada’s Federal Drug Decriminalization Bill? (Filter)

• Maryland Lawmakers Work To Decriminalize Drug Paraphernalia (Marijuana Moment)

• The 5 Craziest Places On Earth to Do Psychedelics (DoubleBlind)

• The Religious Uses of Licit and Illicit Psychoactive Substances in a Branch of the Santo Daime Religion (Chacruna)

• “Largest-Ever” Harm Reduction Ad Campaign Demands Services, Honors the Dead (Filter)

• Naming and shaming drug users is focus group fodder – Labour must do better (LabourList)

• Co-Creating a Psychedelic Commons: A Commoner’s Guide (Chacruna)

• Meet the 16 Most Influential Women Shaping the Future of Psychedelics (Business Insider)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 2.11.22

Cannabis

• South Carolina Medical Marijuana Legalization Bill Officially Approved In Senate, Heads For House Consideration (Marijuana Moment)

• Maryland Lawmakers Introduce Adult-Use Cannabis Legalization Bill (High Times)

• UK trial of medical cannabis and long covid to get underway this month (Cannabis Health News)

• The Super Bowl won’t be lit: no cannabis ads allowed (The Verge)

• Bill Introduced to Raise THC Limit in Hemp to One Percent (High Times)

• Cannabis Store Co-owned By Top Virginia Senator Sells Mislabeled Products With Illegal THC Content, Media Investigation Finds (Marijuana Moment)

• Study Shreds Cannabis ‘Amotivational Syndrome’ Theory (High Times)

• Flower still king of US marijuana market, though supremacy waning (Marijuana Business Daily)

• Oklahoma Becomes Marijuana Legalization Battleground Between Advocates, With Legal Challenges And A New Ballot Initiative (Marijuana Moment)

• New York Cracks Down on Illegal Cannabis Businesses (High Times)

• Missouri Supreme Court Unanimously Orders Medical Marijuana Applicant Disclosures (Marijuana Moment)

• Pennsylvania Senate committee holds first-ever hearing on legalizing recreational marijuana (WGAL)

• Police Seizure Of Marijuana Dispensary Cash Leads To Federal Litigation (Marijuana Moment)

• Cannabis platform Leafly closes merger with SPAC, goes public on Nasdaq (Marijuana Business Daily)

• The Eternal Pricing Struggle of UK Medical Cannabis Patients (TalkingDrugs)

• Weedmaps Ad Satirizes Plight Of Broccoli Emoji As Marijuana Stand-In On Social Media (Marijuana Moment)

• Young cannabis users at increased risk of repeat stroke (Medical News Today)

• Federally Owned Utility Company Walks Back Threat To Block Electricity For Marijuana Businesses (Marijuana Moment)

• Cali Vibes Rocks Long Beach, Allowing Cannabis (High Times)

• How does cannabis use affect brain health? Caution advised, more research needed, experts say (ScienceDaily)

LSD

• Microdose Psychedelics Presents a Molecular Masterclass: The LSD Conference (GlobeNewswire)

Magic Mushrooms

• Psilocybin microdosing does not reduce symptoms of depression or anxiety, according to placebo-controlled study (PsyPost)

• Lawmakers say no to bill legalizing psilocybin-assisted therapy in Maine (The Portland Press Herald)

• Oregon proposes only using one type of mushroom for new psilocybin system, and no pills (OPB)

• More States Follow Oregon’s Lead Toward Legal Psilocybin Therapy (Lucid News)

• Usona Identifies Controlled Crystal Engineering Process for Large-Scale Synthesis of Psilocybin Polymorphs (Business Wire)

• Maine CDC Director Opposes Bill to Legalize Therapeutic Psilocybin (Psychedelic Spotlight)

• The Many Types of Psychedelic Mushrooms (Truffle Report)

• Mazatec Shamanic Knowledge and Psilocybin Mushrooms (Chacruna)

MDMA

• Can MDMA Save a Marriage? (The New York Times)

DMT

• DMT Vape Pen Patent Illustrates a Big Problem in the Psychedelics Industry (Psychedelic Spotlight)

Ayahuasca

• Creating Awareness on Sexual Abuse in Ayahuasca Communities: A Review of Chacruna’s Guidelines (Chacruna)

5-MeO-DMT

• Scientists Create Cell-Based Psychedelic Toad Venom, a Potential 5-MeO-DMT “Bio-Factory” (Lucid News)

Mescaline

• Mescaline As Therapy Is Getting Attention, Despite Stigma (Green Market Report)

Iboga

• Osoyoos Indian Band eyes cutting-edge drug treatment centre (Vancouver Sun)

Novel Psychoactive Substances

• Cybin Announces Grant of U.S. Patent Covering its Proprietary Compound CYB004 (Deuterated DMT) for the Treatment of Anxiety Disorders (Psilocybin Alpha)

Nitrous Oxide

• Another new weapon to beat Corona, first 'nasal spray' launched in India (News Track)

• Nitrous Oxide Safe For Dental Procedures In Children With Sickle Cell Disease: Study (Medical Dialogues)

Ketamine

• Ketamine effectively silences suicidal thoughts, especially in bipolar patients (Study Finds)

• Researching Ketamine for Social Anxiety Disorder (Truffle Report)

• Yale researcher receives grant to study effects of ketamine in individuals with epilepsy (Yale Daily News)

• Trip Tunes: A Conversation with Producer Jon Hopkins About Making Music for Ketamine (DoubleBlind)

• Ketamine Infusions in the Home May Facilitate Safe Treatment Access During the Pandemic (Pharmacy Times)

Miscellaneous

• Can microdosing psychedelics boost mental health? Here’s what the evidence suggests. (National Geographic)

• Utah House Overwhelmingly Approves Psychedelics Study Task Force Bill (Marijuana Moment)

• Maryland Senate Bill Would Provide ‘Cost-Free Access’ To Psychedelics For Military Veterans (Marijuana Moment)

• Psychedelics Offer New Route to Recovery from Eating Disorders (NEO.LIFE)

• Are Psychedelics the Future of Pain Relief? (VICE)

• Michigan Activists Submit Psychedelics Decriminalization Language (High Times)

• DEA Faces Backlash Over Proposed Scheduling Of Five Psychedelic Compounds (Marijuana Moment)

• Proposed Drug-Decrim Ballot Initiative All Set in Washington State (Filter)

• Can Psychedelics Make People More Drawn to Conspiracy Theories? (Sam Woolfe)

• Yes, Psychedelics Do Change Our Metaphysical Beliefs (DoubleBlind)

• Panel Discusses Coalition Building to Unlock Therapeutic Effects of Psychedelics (The Yale School)

• Legal Psychedelics: The U.S. Cities Where Psilocybin, LSD And Others Are Decriminalized (Healing Maps)

• Canada’s Reforms on Psychedelics Are Slowly Taking Shape (Bloomberg)

• Survey Shows 65% of Affected Americans Want Access to Psychedelic Treatments for Mental Health Conditions (Pharmacy Times)

• New Polling by Mind Medicine Australia Reveals Over 60% of Australians Support Increased Access to Psychedelic Medicines (Mind Medicine Australia)

• Big Pharma In Psychedelics: Inside Mindset Pharma’s Deal With Otsuka (Forbes)

• Using Real-World Evidence to Accelerate Psychedelic Drug Development (Truffle Report)

• Is city getting ‘high’ on hallucinating drugs? (The Hindu)

• Drug Euphoria Is a Good Thing, Actually (Filter)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 2.4.22

Cannabis

• Mississippi governor signs law allowing medical marijuana (Leafly)

• The NFL is throwing $1 million into cannabinoid research (Leafly)

• House Officially Approves Marijuana Banking Amendment To Large-Scale Bill Set For Final Passage Friday (Marijuana Moment)

• Delta-8 Debate: The 2018 Farm Bill gave rise to an unlikely intoxicant (Marijuana Business Daily)

• House Advances SAFE Banking Act as Part of the America COMPETES Act (NORML)

• Driving Performance and Cannabis Users’ Perception of Safety - Review (Drug Science)

• Minnesota: Patients’ Access to Herbal Cannabis Products Begins March 1 (NORML)

• Claim of Fentanyl-Laced Cannabis Overdoses in Connecticut was False (High Times)

• Cannabis being used to treat symptoms of Long Covid in new landmark trial (Mirror)

• ‘The science about the benefits of cannabis is limited’: Does legalizing marijuana lead to an increase in tobacco use? (MarketWatch)

• Utah Lawmakers Pass Bill To Protect Medical Cannabis Patients (High Times)

• A Cannabis Monopoly Asteroid is Coming (Marijuana Moment)

• Petition Forces Ohio Lawmakers into Action on Cannabis Legalization (High Times)

• Marijuana legalization push increasingly unites unlikely political bedfellows (Marijuana Business Daily)

• 2021: A Year In Review For The Cannabis Industry (Forbes)

• Top Maryland Lawmaker Files Marijuana Legalization Bill In Anticipation Of Ballot Referendum Passing (Marijuana Moment)

• Pennsylvania Issues Mandatory Recall for Hundreds of Cannabis Products (New Cannabis Ventures)

• Wisconsin Governor Vetoes GOP Bill To Increase Marijuana Extraction Penalties (Marijuana Moment)

• Republican Lawmakers in Virginia Have Drafted New Cannabis Legislation (High Times)

• Marijuana Banking Reform Cleared For House Floor (Again) Following Committee Action On Large-Scale Bill (Marijuana Moment)

• Can Cannabinoids Unlock a Better Understanding of Our Bodies and Brains? (Discover Magazine)

• Nearly One In Ten New Missouri Jobs Came From Medical Marijuana Industry In 2021, Trade Group Report Finds (Marijuana Moment)

• Jackson seeks cannabis exemption as part of shock comeback at age 40 (The Sydney Morning Herald)

LSD

• Fish on acid? Microdosing zebrafish with LSD shows its potential benefits for humans (The Conversation)

• What to know about microdosing LSD (Medical News Today)

Magic Mushrooms

• Virginia Psilocybin Decriminalization Bill Defeated In Senate Committee After Top GOP Lawmaker Flips Support (Marijuana Moment)

• Religious Practice Under Oregon Measure 109 (Psychedelics Today)

• Maine Lawmakers Hear Testimonies For and Against Psilocybin Bill (Truffle Report)

• Seattle Doctor Files DEA Petition To Reschedule Psilocybin For Medical Use (Marijuana Moment)

• America’s only psychedelic mushroom store is a church in Oakland. We observed the sacrament (Leafly)

• Federal Appeals Court Dismisses Cancer Patients’ Case To Use Psilocybin Under Right-To-Try Laws (Marijuana Moment)

• Psyched Wellness Announces Additional Positive Results from the 14-day Oral Toxicity Study of AME-1 (Psilocybin Alpha)

• Health Canada Grants Private Company Approval for Healthcare Professionals to Take Psilocybin, Prove Safety (Truffle Report)

MDMA

• Couple Takes MDMA Right Before Grandfather Dies, Trips in Front of Family (Newsweek)

DMT

• Entheon Biomedical Announces the Approval of DMT Clinical Trial (Psilocybin Alpha)

Ayahuasca

• Yaminawa Women and Ayahuasca: Shamanism, Gender, and History in the Peruvian Amazon (Chacruna)

• Women Who Heal: Musicians in the Urban Ayahuasca Scene (Chacruna)

• Madrinha Rita: Brazilian matriarch of ayahuasca (Chacruna)

5-MeO-DMT

• Inside a 5-MeO-DMT Retreat: Who Should and Shouldn’t Embark on This ‘Hero’s Journey’ (Psychedelic Spotlight)

Peyote

• Mining is Threatening the Peyote Tradition in Mexico (Truffle Report)

Ketamine

• Testimony: Minneapolis police trained to ignore city's civil rights report on ketamine and excited delirium (StarTribune)

• Can Ketamine and A.I. Improve Wellness? (Inc)

• PharmaTher Granted FDA Orphan Drug Designation for Ketamine to Treat Status Epilepticus (Psilocybin Alpha)

Miscellaneous

• Who Will Control the Future of Psychedelics in Colorado? (Westword)

• Utah Lawmakers Vote To Study Benefits Of Psychedelics In Treating Mental Health Disorders (Marijuana Moment)

• Psychedelics Decriminalization Ballot Proposal Filed in Michigan (Truffle Report)

• I Read Every Neuroscience Study On Psychedelics Published Since 2017. Here’s What I Learned (Healing Maps)

• Researchers use linguistic analysis to uncover differences between psychedelic drug experiences (PsyPost)

• Psychedelic therapy effective in reducing suicidality, more trials needed (Healio)

• Psychedelic or Not: Of Mice, 5-HT2A Agonists, and Head Shakes (Psychedelic Science Review)

• One Year on, Oregon Drug Decriminalization Is Boosting Harm Reduction and Housing (Filter)

• Looking Ahead to a Psychedelic 2022 (Psilocybin Alpha)

• The Tortured Double Think of the New Drug Strategy (Transform)

• What Happens When Psychedelic Treatment for PTSD Turns Into a Bad Trip (Slate)

• Are Double-Blind Studies Holding Back Psychedelic Research? (The Dales Report)

• What Research Doesn’t Tell Us About Older Psychedelic Users (Lucid News)

• Jeering Psychedelics: A Critique of Jacques Mabit’s Criticism of Queering Psychedelics (Chacruna)

• Are psychedelics dangerous? - What the research says (Drug Science)

• Psychedelics Without the Trip Could Be 'Healing Magic' for Mental Health (Singularity Hub)

• Clinical study of psychedelic drugs for cancer patients could be a ‘game changer’ (The Salt Lake Tribune)

• Sensible policy on psychedelic drugs is growing more common (The Economist)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 1.28.22

Cannabis

• Thailand Becomes First Country in Asia to Decriminalize Marijuana (TIME)

• New York medical cannabis approved for ‘any’ condition a doctor recommends (Leafly)

• Mississippi: Lawmakers Advance Medical Cannabis Access Bill to Governor’s Desk (NORML)

• Amazon Endorses Federal Cannabis Legalization (High Times)

• Europeans choosing cannabis over ecstasy (The Portugal News)

• Delaware Lawmakers Approve Marijuana Legalization Bill In Committee Vote (Marijuana Moment)

• Arkansas voters could see 3 recreational marijuana initiatives on ballot (Marijuana Business Daily)

• Cannabis Events Come Out of Hiding in New York City (The New York Times)

• North Dakota recreational marijuana measure fails to qualify for ballot (Marijuana Business Daily)

• Wisconsin Republicans Announce Limited Medical Marijuana Legalization Bill (Marijuana Moment)

• Legal Cannabis Opens a Pandora’s Box of Equity Issues (Capital and Main)

• Ohio Lawmakers Will Be Forced To Consider Marijuana Legalization As State Validates Activist Signatures (Marijuana Moment)

• Active Ingredient in Cannabis Protects Aging Brain Cells (Neuroscience News)

• Majority Of Americans Say They’d Vote For A Politician Who Smokes Marijuana, Poll Finds (Marijuana Moment)

• What Happens When You Quit Cannabis? (IFLScience)

• Missouri Marijuana Legalization Measures Take Differing Approaches to Expungement (Marijuana Moment)

• Minnesota Groups Bind Together to Oppose Legal Cannabis (High Times)

• Don’t Feed Marijuana Buds To Donkeys, New Study Warns (Marijuana Moment)

• South Dakota: House Lawmakers Move to Repeal Citizen-Initiated Home Cultivation Rights (NORML)

LSD

• FDA clears phase 2b study of LSD treatment for generalized anxiety (Healio)

Magic Mushrooms

• No difference between psilocybin microdosing and placebo, trial finds (New Atlas)

• Colorado Activists File Revised Ballot Initiatives To Legalize Psilocybin And Establish ‘Healing Centers’ (Marijuana Moment)

• Oregon Lawmakers File Psilocybin Equity Bill As State Implements Legal Use Program (Marijuana Moment)

• Oklahoma Republicans File Bills To Decriminalize Psilocybin And Encourage Research On Medical Benefits (Marijuana Moment)

• Numinus Identified as a Licensed Psilocybin Supplier by Health Canada (Psilocybin Alpha)

• Psilocybin: Following in the Footsteps of Cannabis Along the Path to Legality (JD Supra)

• Psyched Wellness Provides Update on Anti-Inflammatory Study with the National Research Council of Canada (Psilocybin Alpha)

• How is Oregon Preparing for the Facilitated Use of Psilocybin? (Lucid News)

• Red Light Holland’s Partner CCrest Laboratories Approved By Health Canada to Supply Psilocybin to the Special Access Program (Psilocybin Alpha)

• Diamond Therapeutics Looks At Low-Dose Psilocybin (The Dales Report)

• Mydecine Partners with Combat Stress to Treat Post-Traumatic Stress Disorder in Veterans (Psilocybin Alpha)

DMT

• Algernon Pharmaceuticals Discloses Novel Salt Patent Strategy as Part of its Psychedelic Drug DMT Intellectual Property (Psilocybin Alpha)

5-MeO-DMT

• A Psychedelic Craze Has Taken Hold Among The Rich, Toad Venom (Baller Alert)

Novel Psychoactive Substances

• The Future of Psychedelic Medicine Will Be Drugs You’ve Never Heard Of (VICE)

• Awakn Life Sciences Files Patent Application for a New Class of Entactogen-Like Molecules to Treat a Broad Range of Addictions (Psilocybin Alpha)

Ketamine

• New study indicates ketamine is less effective than electroconvulsive therapy for severe depression (PsyPost)

• Ketamine Intravenous Therapy Shown to Improve Depression, Reduce Suicidal Ideation (Psych Central)

• Have We Eliminated Stigma Surrounding Ketamine-Assisted Treatment? (Volteface)

Miscellaneous

• Missouri Legislators Introduce Bill to Give Terminally Ill Patients Access to Psychedelics (DoubleBlind)

• Virginia House Committee Pushes Back Psychedelics Decriminalization Bill Until 2023, But Senate Proposal Still Pending (Marijuana Moment)

• Lawmakers Propose Study of Natural Psychedelics for Mental Health Use (Westword)

• Introducing Vital: Immersive, Inclusive, and Personal Psychedelic Training for Professionals (Psychedelics Today)

• Psychedelic Perceptions in 2021: Popular Culture & Controversy (Psilocybin Alpha)

• Family Tripping: How Multigenerational Psychedelic Drug Experiences Can Provide Connection (Everything Zoomer)

• Psychedelic Capital: Public vs. Private Markets (Truffle Report)

• Sensible policy on psychedelic drugs is growing more common (The Economist)

• Inside the Growing Wellness Trend of Psilocybin Mushroom Microdosing (The Hollywood Reporter)

• Hallucinogen chemistry guides antidepressant drug discovery (Chemical and Engineering News)

• Decriminalize Nature and Students For Sensible Drug Policy Create a Community Healing Alliance (High Times)

• Have You Taken Psychedelics? Participate In The Canadian Psychedelics Survey Sponsored By MAPS PBC (The Dales Report)

• Laganja Estranja’s Psychedelic Life (DoubleBlind)

• Psychedelics and Parkinson’s Disease: Improving Patient Quality of Life (Truffle Report)

• Psychedelic and Plant Medicines: A Portal to Transformative Realms of Possibility (Nonprofit Quarterly)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.